NRXP
NASDAQ · Pharmaceuticals
Nrx Pharmaceuticals Inc
$3.15
+0.03 (+0.96%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+575.6% upside
Low Target
$14.65
Average Target
$21.28
High Target
$27.46
Current Price
$3.15
Current
$3.15
$3.15
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Scenario Analysis
Bear Case
$14.65
365.1%
Low target
Base Case
$21.28
+575.6%
Avg target
Bull Case
$27.46
+771.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$5.06
-37.7% from high
52-Week Low
$1.62
+94.4% from low
Target vs 52W High
$21.28
+321.0% vs high
Next Earnings Report
Aug 17, 2026
8d
until earnings
EPS Est: $0.07
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals